479 related articles for article (PubMed ID: 18691078)
1. Neurofibrillary tangles and senile plaques in Alzheimer's brains are associated with reduced capillary expression of vascular endothelial growth factor and endothelial nitric oxide synthase.
Provias J; Jeynes B
Curr Neurovasc Res; 2008 Aug; 5(3):199-205. PubMed ID: 18691078
[TBL] [Abstract][Full Text] [Related]
2. Correlation analysis of capillary APOE, VEGF and eNOS expression in Alzheimer brains.
Provias J; Jeynes B
Curr Alzheimer Res; 2011 Mar; 8(2):197-202. PubMed ID: 21143177
[TBL] [Abstract][Full Text] [Related]
3. Significant negative correlations between capillary expressed eNOS and Alzheimer lesion burden.
Jeynes B; Provias J
Neurosci Lett; 2009 Oct; 463(3):244-8. PubMed ID: 19660523
[TBL] [Abstract][Full Text] [Related]
4. The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison.
Jeynes B; Provias J
Acta Neuropathol; 2006 Oct; 112(4):417-27. PubMed ID: 16830133
[TBL] [Abstract][Full Text] [Related]
5. Evidence for altered LRP/RAGE expression in Alzheimer lesion pathogenesis.
Jeynes B; Provias J
Curr Alzheimer Res; 2008 Oct; 5(5):432-7. PubMed ID: 18855584
[TBL] [Abstract][Full Text] [Related]
6. An investigation into the role of P-glycoprotein in Alzheimer's disease lesion pathogenesis.
Jeynes B; Provias J
Neurosci Lett; 2011 Jan; 487(3):389-93. PubMed ID: 21047545
[TBL] [Abstract][Full Text] [Related]
7. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
[TBL] [Abstract][Full Text] [Related]
8. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease.
Armstrong RA
Folia Neuropathol; 2009; 47(4):289-99. PubMed ID: 20054780
[TBL] [Abstract][Full Text] [Related]
9. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
Thal DR; Fändrich M
Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
[No Abstract] [Full Text] [Related]
10. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
[TBL] [Abstract][Full Text] [Related]
11. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
12. Beta-amyloid accumulation in neurovascular units following brain embolism.
Han F; Fukunaga K
J Pharmacol Sci; 2009 Oct; 111(2):101-9. PubMed ID: 19783863
[TBL] [Abstract][Full Text] [Related]
13. Binding of curcumin to senile plaques and cerebral amyloid angiopathy in the aged brain of various animals and to neurofibrillary tangles in Alzheimer's brain.
Mutsuga M; Chambers JK; Uchida K; Tei M; Makibuchi T; Mizorogi T; Takashima A; Nakayama H
J Vet Med Sci; 2012 Jan; 74(1):51-7. PubMed ID: 21891973
[TBL] [Abstract][Full Text] [Related]
14. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
[TBL] [Abstract][Full Text] [Related]
15. Transglutaminases and transglutaminase-catalyzed cross-links colocalize with the pathological lesions in Alzheimer's disease brain.
Wilhelmus MM; Grunberg SC; Bol JG; van Dam AM; Hoozemans JJ; Rozemuller AJ; Drukarch B
Brain Pathol; 2009 Oct; 19(4):612-22. PubMed ID: 18673368
[TBL] [Abstract][Full Text] [Related]
16. Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia.
Janocko NJ; Brodersen KA; Soto-Ortolaza AI; Ross OA; Liesinger AM; Duara R; Graff-Radford NR; Dickson DW; Murray ME
Acta Neuropathol; 2012 Nov; 124(5):681-92. PubMed ID: 22968369
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Styrylbenzene analog- FSB and its affinity to bind parenchymal plaques and tangles in patients of Alzheimer's disease.
Setti SE; Das N; Raymick J; Hanig J; Sarkar S
Metab Brain Dis; 2022 Mar; 37(3):639-651. PubMed ID: 35064472
[TBL] [Abstract][Full Text] [Related]
18. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
[TBL] [Abstract][Full Text] [Related]
19. Fibrillar amyloid-beta affects neurofibrillary changes but only in neurons already involved in neurofibrillary degeneration.
Wegiel J; Bobinski M; Tarnawski M; Dziewiatkowski J; Popovitch E; Miller DC; Wisniewski T; Golomb J; de Leon MJ; Reisberg B
Acta Neuropathol; 2001 Jun; 101(6):585-90. PubMed ID: 11515787
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
